SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19
PerkinElmer
JUNE 3, 2022
There is therefore an urgent need for the development of effective antivirals to complement vaccination efforts and prevent more severe disease, hospitalization, and death. Viral protease inhibitors that block enzymes critical for viral replication have long been used in the treatment of human immunodeficiency (HIV) and hepatitis C viruses.
52 
Let's personalize your content